Trends in Reflexive Hepatitis C Virus Testing in a National US Laboratory: A Retrospective Study From 2018 to 2024
Clinical Infectious Diseases · 2026
DOI: 10.1093/cid/ciag227 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Infectious Diseases, 2026. Verfasst von Min Kyung Lee und 3 weiteren Autor:innen. Beteiligte Einrichtung: Diagnostics, Labcorp, Burlington, North Carolina, USA. Hauptthemen laut MEDLINE: Hepatitis C, Hepacivirus, Mass Screening. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben. Gefördert von: Labcorp.
Abstract (Originalsprache)
Background
In 2019 and 2020, universal hepatitis C screening of adults was recommended by clinical guideline authorities, including the Centers for Disease Control and Prevention (CDC). In 2023, CDC recommendations emphasized the importance of reflexive hepatitis C testing in which samples positive for hepatitis C virus (HCV) antibody (Ab) automatically reflex to viral RNA nucleic acid amplification testing (NAAT). Laboratory stewardship initiatives to guide compliance with expanded guidelines were implemented.
Methods
We conducted a retrospective review of 38 233 788 specimens with HCV Ab testing and 1 423 543 follow-up HCV RNA NAAT performed from 2018 to 2024 to evaluate the impact of expanded hepatitis C guidelines and laboratory stewardship initiatives.
Results
From 2018 to 2024, reflexive hepatitis C testing volumes increased annually, while orders for standalone HCV Ab testing and HCV Ab positivity rates steadily declined. Among HCV Ab–positive individuals, the percentage with reflexive testing increased from 21.9% in 2018 to 82.2% in 2024 (Ƭ = 1.00, P = .003) and RNA testing rates increased from 66.4% in 2018 to 89.3% in 2024 (Ƭ = 1.00, P = .003). Follow-up RNA testing was increasingly completed earlier in HCV Ab–positive individuals with the same-day RNA testing rate increasing from 38.0% in 2018 to 82.2% in 2024. HCV RNA positivity decreased 19.2% during the study period.
Conclusions
Expanded hepatitis C screening guidelines highlighting the importance of reflexive HCV testing and subsequent internal laboratory stewardship initiatives likely contributed to the increased utilization of reflexive hepatitis C testing and the decreased time to identification of active hepatitis C infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Diagnostics, Labcorp, Burlington, North Carolina, USA.
ORCID-Profile: David Alfego, Laura Gillim
Förderung
- Labcorp
Zitieren
APA
Lee, M. K., Alfego, D., Walworth, C., & Gillim, L. (2026). Trends in Reflexive Hepatitis C Virus Testing in a National US Laboratory: A Retrospective Study From 2018 to 2024. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciag227
Vancouver
Lee MK, Alfego D, Walworth C, Gillim L. Trends in Reflexive Hepatitis C Virus Testing in a National US Laboratory: A Retrospective Study From 2018 to 2024. Clinical Infectious Diseases. 2026. doi:10.1093/cid/ciag227
BibTeX
@article{Lee2026,
author = {Lee, Min Kyung and Alfego, David and Walworth, Charles and Gillim, Laura},
title = {Trends in Reflexive Hepatitis C Virus Testing in a National US Laboratory: A Retrospective Study From 2018 to 2024},
journal = {Clinical Infectious Diseases},
year = {2026},
doi = {10.1093/cid/ciag227}
}
EUVIMED